Sodium-Glucose Transporter 2

• 

  Subject Areas on Research

  • Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum. 
  • Eligibility varies among the 4 sodium-glucose cotransporter-2 inhibitor cardiovascular outcomes trials: implications for the general type 2 diabetes US population. 
  • Functional implications of sexual dimorphism of transporter patterns along the rat proximal tubule: modeling and analysis. 
  • Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues. 
  • The Limited Role of Glucagon for Ketogenesis During Fasting or in Response to SGLT2 Inhibition. 
  • The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors.